Global Prostate Cancer Therapeutic Market Research Report 2016

Publisher Name :
Date: 02-Sep-2016
No. of pages: 125
Inquire Before Buying

Notes:

Production, means the output of Prostate Cancer Therapeutic

Revenue, means the sales value of Prostate Cancer Therapeutic

This report studies Prostate Cancer Therapeutic in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

- Pfizer Inc. (USA)

- Abbott Laboratories (USA)

- Genentech Inc. (USA)

- GlaxoSmithKline Plc (UK)

- Immunomedics, Inc. (USA)

- Indevus Pharmaceuticals Inc. (USA)

- Novartis AG (Switzerland)

- OSI Pharmaceuticals, Inc. (USA)

- Paladin Labs Inc. (Canada)

- ALZA Corporation (USA)

- Amgen Inc. (USA)

- AstraZeneca PLC (UK)

- Medimmune, LLC (USA)

- Bristol-Myers Squibb Company (USA)

- Cell Genesys Inc. (USA)

- Dendreon Corporation (USA)

- EUSA Pharma, (USA) Inc. (USA)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Progenics Pharmaceuticals, Inc. (USA)

- Sanofi-Aventis SA (France)

- Spectrum Pharmaceuticals, Inc. (USA)

- Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Prostate Cancer Therapeutic in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on consumption, market share and growth rate of Prostate Cancer Therapeutic in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Prostate Cancer Therapeutic Market Research Report 2016

Table of Contents
Global Prostate Cancer Therapeutic Market Research Report 2016
1 Prostate Cancer Therapeutic Market Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutic
1.2 Prostate Cancer Therapeutic Segment by Type
1.2.1 Global Production Market Share of Prostate Cancer Therapeutic by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Prostate Cancer Therapeutic Segment by Application
1.3.1 Prostate Cancer Therapeutic Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Prostate Cancer Therapeutic Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Prostate Cancer Therapeutic (2011-2021)
2 Global Prostate Cancer Therapeutic Market Competition by Manufacturers
2.1 Global Prostate Cancer Therapeutic Production and Share by Manufacturers (2015 and 2016)
2.2 Global Prostate Cancer Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Prostate Cancer Therapeutic Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Prostate Cancer Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 Prostate Cancer Therapeutic Market Competitive Situation and Trends
2.5.1 Prostate Cancer Therapeutic Market Concentration Rate
2.5.2 Prostate Cancer Therapeutic Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Prostate Cancer Therapeutic Production, Revenue (Value) by Region (2011-2016)
3.1 Global Prostate Cancer Therapeutic Production and Market Share by Region (2011-2016)
3.2 Global Prostate Cancer Therapeutic Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
4 Global Prostate Cancer Therapeutic Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Prostate Cancer Therapeutic Consumption by Regions (2011-2016)
4.2 North America Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
5 Global Prostate Cancer Therapeutic Production, Revenue (Value), Price Trend by Type
5.1 Global Prostate Cancer Therapeutic Production and Market Share by Type (2011-2016)
5.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)
5.3 Global Prostate Cancer Therapeutic Price by Type (2011-2016)
5.4 Global Prostate Cancer Therapeutic Production Growth by Type (2011-2016)
6 Global Prostate Cancer Therapeutic Market Analysis by Application
6.1 Global Prostate Cancer Therapeutic Consumption and Market Share by Application (2011-2016)
6.2 Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Prostate Cancer Therapeutic Manufacturers Profiles/Analysis
7.1 Pfizer Inc. (USA)
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories (USA)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Genentech Inc. (USA)
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline Plc (UK)
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Immunomedics, Inc. (USA)
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Novartis AG (Switzerland)
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Paladin Labs Inc. (Canada)
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 ALZA Corporation (USA)
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Prostate Cancer Therapeutic Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Amgen Inc. (USA)
7.12 AstraZeneca PLC (UK)
7.13 Medimmune, LLC (USA)
7.14 Bristol-Myers Squibb Company (USA)
7.15 Cell Genesys Inc. (USA)
7.16 Dendreon Corporation (USA)
7.17 EUSA Pharma, (USA) Inc. (USA)
7.18 F. Hoffmann-La Roche Ltd. (Switzerland)
7.19 Progenics Pharmaceuticals, Inc. (USA)
7.20 Sanofi-Aventis SA (France)
7.21 Spectrum Pharmaceuticals, Inc. (USA)
7.22 Takeda Pharmaceutical Company Limited (Japan)
8 Prostate Cancer Therapeutic Manufacturing Cost Analysis
8.1 Prostate Cancer Therapeutic Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Prostate Cancer Therapeutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Prostate Cancer Therapeutic Market Forecast (2016-2021)
12.1 Global Prostate Cancer Therapeutic Production, Revenue Forecast (2016-2021)
12.2 Global Prostate Cancer Therapeutic Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Prostate Cancer Therapeutic Production Forecast by Type (2016-2021)
12.4 Global Prostate Cancer Therapeutic Consumption Forecast by Application (2016-2021)
12.5 Prostate Cancer Therapeutic Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Prostate Cancer Therapeutic
Figure Global Production Market Share of Prostate Cancer Therapeutic by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Prostate Cancer Therapeutic Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Prostate Cancer Therapeutic Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Prostate Cancer Therapeutic Production of Key Manufacturers (2015 and 2016)
Table Global Prostate Cancer Therapeutic Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Therapeutic Production Share by Manufacturers
Figure 2016 Prostate Cancer Therapeutic Production Share by Manufacturers
Table Global Prostate Cancer Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Prostate Cancer Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table 2016 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table Global Market Prostate Cancer Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Prostate Cancer Therapeutic Average Price of Key Manufacturers in 2015
Table Manufacturers Prostate Cancer Therapeutic Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Therapeutic Product Type
Figure Prostate Cancer Therapeutic Market Share of Top 3 Manufacturers
Figure Prostate Cancer Therapeutic Market Share of Top 5 Manufacturers
Table Global Prostate Cancer Therapeutic Production by Regions (2011-2016)
Figure Global Prostate Cancer Therapeutic Production and Market Share by Regions (2011-2016)
Figure Global Prostate Cancer Therapeutic Production Market Share by Regions (2011-2016)
Figure 2015 Global Prostate Cancer Therapeutic Production Market Share by Regions
Table Global Prostate Cancer Therapeutic Revenue by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue Market Share by Regions (2011-2016)
Table 2015 Global Prostate Cancer Therapeutic Revenue Market Share by Regions
Table Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Prostate Cancer Therapeutic Consumption Market by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Consumption Market Share by Regions (2011-2016)
Figure Global Prostate Cancer Therapeutic Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Prostate Cancer Therapeutic Consumption Market Share by Regions
Table North America Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Europe Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table China Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Japan Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table India Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Global Prostate Cancer Therapeutic Production by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Production Share by Type (2011-2016)
Figure Production Market Share of Prostate Cancer Therapeutic by Type (2011-2016)
Figure 2015 Production Market Share of Prostate Cancer Therapeutic by Type
Table Global Prostate Cancer Therapeutic Revenue by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Prostate Cancer Therapeutic by Type (2011-2016)
Figure 2015 Revenue Market Share of Prostate Cancer Therapeutic by Type
Table Global Prostate Cancer Therapeutic Price by Type (2011-2016)
Figure Global Prostate Cancer Therapeutic Production Growth by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Consumption by Application (2011-2016)
Table Global Prostate Cancer Therapeutic Consumption Market Share by Application (2011-2016)
Figure Global Prostate Cancer Therapeutic Consumption Market Share by Application in 2015
Table Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)
Figure Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Prostate Cancer Therapeutic Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALZA Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Prostate Cancer Therapeutic Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Therapeutic
Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic
Figure Prostate Cancer Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Therapeutic
Table Distributors/Traders List
Figure Global Prostate Cancer Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Global Prostate Cancer Therapeutic Production Forecast by Regions (2016-2021)
Table Global Prostate Cancer Therapeutic Consumption Forecast by Regions (2016-2021)
Table Global Prostate Cancer Therapeutic Production Forecast by Type (2016-2021)
Table Global Prostate Cancer Therapeutic Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Dental Bone Graft Substitutes Market Professional Survey Report 2017
    Published: 27-Apr-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Dental Bone Graft Substitutes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Geistlich - Zimmer - DePuy Synthes - Biomet - S......
  • Asia-Pacific Interferon Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Interferon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Interferon for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Hyaluronic Acid Solution Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the Asia-Pacific Hyaluronic Acid Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Hyaluronic Acid Solution for these regions, from 2012 to 2022 (forecast), including - China - Japan - Sou......
  • Asia-Pacific Gastrointestinal Surgery Tissue Adhesive Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the Asia-Pacific Gastrointestinal Surgery Tissue Adhesive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Surgery Tissue Adhesive for these regions, from 2012 to 2022 (forecast), including - Chi......
  • Asia-Pacific Citrus Bioflavonoids Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Citrus Bioflavonoids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Citrus Bioflavonoids for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Bioresorbable Implants Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the Asia-Pacific Bioresorbable Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Bioresorbable Implants for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kor......
  • Asia-Pacific Anti-Infectives Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Anti-Infectives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Infectives for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Albendazole Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the Asia-Pacific Albendazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Albendazole for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • EMEA (Europe, Middle East and Africa) Vascular Endothelial Growth Factor Inhibitor Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Vascular Endothelial Growth Factor Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Vascular Endothelial Growth Factor Inhibitor for these regions, from 2012 to 2022 (forecast) - Europe:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs